603858 XD步长制药
2026/09 - 九个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)7.7543.567-5.0732.660-11.476
总资产报酬率 ROA (%)4.1201.871-2.7541.489-6.679
投入资产回报率 ROIC (%)5.4032.526-3.7382.021-8.879

边际利润分析
销售毛利率 (%)60.12662.94759.77068.15271.691
营业利润率 (%)12.0004.767-2.2423.292-8.357
息税前利润/营业总收入 (%)12.8325.451-2.2043.671-7.664
净利润/营业总收入 (%)9.0301.619-6.3821.147-10.641

收益指标分析
经营活动净收益/利润总额(%)105.078238.635-169.066258.509-135.174
价值变动净收益/利润总额(%)-7.139-53.063-3.5234.799-0.217
营业外收支净额/利润总额(%)-2.241-6.02232.450-10.5090.788

偿债能力分析
流动比率 (X)1.2741.1011.0611.2081.292
速动比率 (X)0.5330.4730.4100.4890.747
资产负债率 (%)49.25150.96649.25645.54944.082
带息债务/全部投入资本 (%)25.82926.42425.37820.70520.117
股东权益/带息债务 (%)268.379265.055282.107365.294379.042
股东权益/负债合计 (%)110.167102.076107.311122.075127.755
利息保障倍数 (X)11.7165.711-1.9755.304-10.093

营运能力分析
应收账款周转天数 (天)18.60723.76140.24742.50037.214
存货周转天数 (天)384.892373.283388.435372.069324.192